Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA)
NCT ID: NCT00839020
Last Updated: 2016-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
26 participants
INTERVENTIONAL
2007-11-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
NCT04976972
Trial Comparing Navigated and Conventional Implantation Techniques in Knee Replacement Surgery
NCT00431509
Computer Navigation vs Conventional Technique in Knee Arthroplasty
NCT00782444
Kinematic Versus Mechanical Alignment in Total Knee Replacement
NCT04384913
Prospective Randomized Trial of Navigated and Conventional TKA
NCT01022099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients receive a Columbus knee prosthesis and in both groups an OrthoPilot navigation system is used to control the alignment. Pain intensity using the Visual Analogue Scale (VAS) and concomitant pain medication intake are documented daily during the first 20 days after operation. As long as the patient is hospitalized the Range of Motion will also be documented daily. Knee society score, oxford score, as well as the WOMAC score are monitored pre- and postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Navigated total knee arthroplasty with a minimally invasive approach
Navigated TKA with a minimally invasive approach
Navigated total knee arthroplasty with a minimally invasive approach
2
Navigated total knee arthroplasty with a conventional approach
Navigated TKA with a conventional approach
A navigated total knee arthroplasty is performed using the Orthopilot navigation system. A conventional approach is performed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Navigated TKA with a minimally invasive approach
Navigated total knee arthroplasty with a minimally invasive approach
Navigated TKA with a conventional approach
A navigated total knee arthroplasty is performed using the Orthopilot navigation system. A conventional approach is performed
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* agreement to participate in this study
Exclusion Criteria
* varus or valgus deformity \>20°
* Range of Motion (ROM) \<75° flexion/extension
* concomitant diseases like: rheumatoid arthritis osteoporosis intake of cortisone diabetes former operations on the concerned knee
* infections in the operated joint during the follow-up period
* Thromboses during the follow-up period
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Lampe, MD
Role: PRINCIPAL_INVESTIGATOR
Schön Kliniken Klinikum Eilbek
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frank Lampe, MD
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIOS-TKR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.